PATENT CLAIM ANALYSIS

Application Number: 16086690
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "205100"]

Abstract:
The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and non-replicating immunogen of  Mycoplasma hyopneumoniae  and an adjuvant containing a nano-emulsion of mineral oil in water, for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with  Mycoplasma hyopneumoniae  by administration of the vaccine into the dermis of the animal.

Claim (Index 19):
A vaccine of  claim 16 , wherein the non-replicating immunogen of PCV2 is recombinantly expressed ORF2 protein of PCV2.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15100880', '15038765', '15480973', '13850329', '15480949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8177160561026625
- 35 USC 102 Novelty (BERT): 0.5749953962472578
- Combined Prediction Score: 0.7934439901171221
- Mean Citation Score: 474.92419
- Max Citation Score: 528.7849
- Similarity Product: 370.06583786458367

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test